Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

What is the trial about?

Evaluate an investigational treatment aimed at maintaining or improving your child’s response to previous treatments.

Who can participate?

Children undergoing treatment for high risk neuroblastoma.

What is involved?

Length of study is 6 months. Tests and procedures performed include: Physical exam; Blood tests; Bone marrow tests; Various scans; Tests of kidney function; Tests of lung and heart function; Urine tests.

Contact Nemours Clinical Trials

Trial Name: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

COG#: ANBL0032

Contact Information

(800) 354-5690
clinicaltrials@nemours.org